Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nutrition and cancer. Recent developments.

G K Ogilvie1, D M Vail

  • 1From the Comparative Oncology Unit, Colorado State University College of Veterinary Medicine and Biomedical Sciences, Fort Collins.

The Veterinary Clinics of North America. Small Animal Practice
|July 1, 1990
PubMed
Summary

Cancer cachexia causes involuntary weight loss in animals due to metabolic issues. Early recognition and nutritional support are crucial for improving quality of life and cancer treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.

Journal of veterinary internal medicine·2017
Same author

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs.

Journal of veterinary internal medicine·2017
Same author

Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses.

Veterinary and comparative oncology·2017
Same author

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.

Veterinary and comparative oncology·2017
Same author

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma.

Journal of veterinary internal medicine·2017
Same author

Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study.

Veterinary and comparative oncology·2016

Area of Science:

  • Veterinary Medicine
  • Oncology
  • Metabolic Syndrome

Background:

  • Cancer cachexia is a complex syndrome characterized by involuntary weight loss.
  • It involves profound metabolic abnormalities affecting carbohydrate, lipid, and protein metabolism.
  • This paraneoplastic syndrome impacts a significant percentage of animals with cancer, often before clinical signs appear.

Purpose of the Study:

  • To highlight the importance of understanding metabolic abnormalities in cancer cachexia for veterinarians.
  • To guide prognosis determination and selection of optimal supportive therapies.
  • To discuss nutritional management strategies for cancer-bearing animals.

Main Methods:

  • Review of current understanding of cancer cachexia's metabolic effects.

Related Experiment Videos

  • Discussion of diagnostic and prognostic implications for veterinarians.
  • Evaluation of nutritional support options, including oral, enteral, and parenteral feeding.

    • Main Results:

    • Cancer cachexia significantly alters animal metabolism, impacting quality of life and treatment response.
    • Veterinary understanding of these metabolic changes is vital for effective patient management.
    • Nutritional support is a cornerstone of managing cancer cachexia.

    Conclusions:

    • Early identification and management of metabolic abnormalities in cancer cachexia are critical.
    • Veterinarians must consider nutritional interventions tailored to the individual patient.
    • Prioritizing oral nutrition, followed by enteral and parenteral routes, optimizes supportive care.